|
OR2A7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.05069999981156E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.80039999978455E-07 |
| Normal-vs-Stage2 |
1.74537999999558E-05 |
| Normal-vs-Stage3 |
2.58500000294148E-08 |
| Normal-vs-Stage4 |
7.69350000373592E-08 |
| Stage1-vs-Stage2 |
8.896600E-01 |
| Stage1-vs-Stage3 |
4.483800E-02 |
| Stage1-vs-Stage4 |
1.344240E-01 |
| Stage2-vs-Stage3 |
1.334600E-01 |
| Stage2-vs-Stage4 |
1.979820E-01 |
| Stage3-vs-Stage4 |
9.869600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.89699999942184E-08 |
| Normal-vs-AfricanAmerican |
2.120700E-03 |
| Normal-vs-Asian |
1.641550E-03 |
| Caucasian-vs-AfricanAmerican |
4.120400E-02 |
| Caucasian-vs-Asian |
1.053950E-02 |
| AfricanAmerican-vs-Asian |
7.745200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.82579999955068E-07 |
| Normal-vs-Female |
2.44500000023962E-07 |
| Male-vs-Female |
8.573400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.65890000017421E-07 |
| Normal-vs-Age(41-60Yrs) |
4.93419999969547E-07 |
| Normal-vs-Age(61-80Yrs) |
1.86439999994015E-07 |
| Normal-vs-Age(81-100Yrs) |
1.11769999922018E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.142000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.140600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.757600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.962000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.637720E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.032300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.953600E-02 |
| Classical-VS-Follicular |
2.744800E-01 |
| Classical-VS-Other |
9.209600E-01 |
| Classical-VS-Normal |
4.60169999993987E-07 |
| Tall-VS-Follicular |
1.086330E-02 |
| Tall-VS-Other |
2.688000E-01 |
| Tall-VS-Normal |
1.72259999597912E-08 |
| Follicular-VS-Other |
8.165800E-01 |
| Follicular-VS-Normal |
2.08309999999434E-05 |
| Other-VS-Normal |
4.452400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.17270000044023E-07 |
| Normal-vs-N1 |
1.3100999995963E-07 |
| N0-vs-N1 |
4.438400E-01 |
|
|
